Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Integra LifeSciences Completes Sale of Extremities Business to Smith+Nephew - Orthopedic Design & Technology
OEM News

Integra LifeSciences Completes Sale of Extremities Business to Smith+Nephew

Includes ankle and shoulder arthroplasty and hand and wrist product lines.

Integra LifeSciences Holdings Corporation, a leading global medical technology company, has completed its previously announced divestiture of its Extremity Orthopedics business to Smith+Nephew.
 
Smith+Nephew payed $240 million in cash for the business.
 
“With this divestiture, we will now be in an even stronger position to capitalize on our core products and technologies in neurosurgery and regenerative medicine, and provide greater value to our customers and shareholders,” said Peter Arduini, president and CEO, Integra LifeSciences. “We want to thank the orthopedics team for their contributions to Integra’s success and wish them all the best for their future.”
 
Piper Sandler & Co. is serving as financial advisor and Morgan, Lewis & Bockius LLP is acting as legal advisor to Integra.

Add us as a preferred source on Google

Get the latest Orthopedic Design & Technology news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters